Enveric Biosciences, Inc. (ENVB)
1.41
+0.04
(+2.92%)
USD |
NASDAQ |
Sep 02, 13:18
Enveric Biosciences Cash and Short Term Investments (Quarterly) : 8.296M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 8.296M |
| March 31, 2026 | 4.909M |
| December 31, 2025 | 4.678M |
| September 30, 2025 | 3.758M |
| June 30, 2025 | 2.850M |
| March 31, 2025 | 4.294M |
| December 31, 2024 | 2.241M |
| September 30, 2024 | 3.112M |
| June 30, 2024 | 3.503M |
| March 31, 2024 | 6.356M |
| December 31, 2023 | 2.288M |
| September 30, 2023 | 4.267M |
| June 30, 2023 | 7.081M |
| March 31, 2023 | 12.56M |
| December 31, 2022 | 17.72M |
| September 30, 2022 | 21.20M |
| June 30, 2022 | 18.01M |
| March 31, 2022 | 21.69M |
| December 31, 2021 | 17.36M |
| September 30, 2021 | 21.45M |
| June 30, 2021 | 20.62M |
| March 31, 2021 | 22.66M |
| December 31, 2020 | |
| September 30, 2020 | 2.840M |
| June 30, 2020 | 2.088M |
| Date | Value |
|---|---|
| March 31, 2020 | 1.267M |
| December 31, 2019 | 0.4314M |
| September 30, 2019 | 0.4997M |
| June 30, 2019 | 1.601M |
| March 31, 2019 | 1.723M |
| December 31, 2018 | 1.371M |
| September 30, 2018 | 2.064M |
| June 30, 2018 | 0.9151M |
| March 31, 2018 | 1.763M |
| December 31, 2017 | 4.882M |
| September 30, 2017 | 0.927M |
| June 30, 2017 | 1.124M |
| March 31, 2017 | 1.896M |
| December 31, 2016 | 1.463M |
| September 30, 2016 | 2.914M |
| June 30, 2016 | 3.604M |
| March 31, 2016 | 0.5052M |
| December 31, 2015 | 1.961M |
| September 30, 2015 | 5.067M |
| June 30, 2015 | 4.378M |
| March 31, 2015 | 0.0039M |
| December 31, 2014 | 0.0051M |
| September 30, 2014 | 0.0091M |
| June 30, 2014 | 0.0078M |
| March 31, 2014 | 0.0225M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| LENZ Therapeutics, Inc. | 220.00M |
| Impact BioMedical, Inc. | 0.01M |
| ANI Pharmaceuticals, Inc. | 375.87M |
| Corcept Therapeutics, Inc. | 308.20M |
| Veru, Inc. | 25.79M |